FTL008.17

N/A

Report date: 2024/11/05 09:55:41

First In Class

Base Information

Drug NameFTL008.17

Drug Alias NameFTL008.17FTL-008.17

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 9Tumor-associated antigen modulators

TargetsTumor necrosis factor receptor superfamily member 9Tumor-associated antigen

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesSound(Chengdu)Biopharmacauticals Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesSound(Chengdu)Biopharmacauticals Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A